Dec 12, 2024
Exclusive 20% Off on Your Eye Care Essentials!
As part of our ongoing commitment to your eye health, we wanted to alert you about our partnership with DryEye Rescue, a trusted provider of specialized eye care products.…
Resources
Dec 10, 2024
‘Not all chocolate is created equal’: New data imply the dark variety lowers diabetes risk
By: Andrew (Drew) Rhoades Fact checked by: Gina Brockenbrough, MA Key takeaways: Eating 5 ounces or more of chocolate a week lowered type 2 diabetes risk. Results showed no link…
Dec 10, 2024
ARCHER trial shows benefit of ANX007 on vision loss in geographic atrophy
By: Michela Cimberle Fact checked by Christine Klimanskis, ELS BARCELONA, Spain — In the phase 2 ARCHER trial, ANX007, a novel C1q inhibitor with neuroprotective properties, showed consistent protection against loss of…
Dec 9, 2024
Is Nutrition The Culprit? With Dr. Poteet
A new video discusses nutrition and its affects on our bodies and our eyes. Did you know your nutrition can impact your risk of disease? Dr. Julie Poteet is a…
Dec 3, 2024
Sun Pharma announces positive Phase 4 data results in dry eye disease
Author(s): David Hutton Key Takeaways Cyclosporine ophthalmic solution 0.09% significantly improves dry eye disease symptoms in patients inadequately controlled on Restasis. The Phase 4 study showed sustained improvements in corneal…
Nov 27, 2024
Happy Thanksgiving
Happy Thanksgiving from our families to yours. We are grateful for your support and friendship. We will be closed on Thursday & Friday in observance of the Holiday.
Nov 22, 2024
Adverum reports positive 52-week, 4-year data for wet AMD gene therapy
by: Alex Young & Anthony DeFino Adverum Biotechnologies reported positive 52-week data from the phase 2 LUNA trial as well as long-term follow-up results from the OPTIC trial of Ixo-vec…
Nov 22, 2024
Early positive data reported for geographic atrophy modifier gene therapy
Key takeaways: Low-dose OCU410 slowed lesion growth, preserved retinal tissue, and stabilized visual function in three patients. No drug-related serious adverse events were reported. OCU410, a single-dose modifier gene therapy,…
Nov 18, 2024
Understanding blue light: Making sense of the spectrum
By Thomas A. Wong, OD, FAAO, FNAP & Karl Citek, OD, PhD, FAAO A new classification system helps patients reach informed decisions.
Nov 18, 2024
4 favorite foods with the most toxic plasticizers
By Anastasia Climan, RDN, CD-N | Fact-checked by Barbara Bekiesz | Published November 15, 2024 Key Takeaways The use of phthalates in food processing and packaging has led to widespread daily exposure, often in foods that are marketed…
Nov 12, 2024
Pistachios take over carrots as ultimate weapon for better, sharper vision?
Scientists have found nutty substitute for people seeking to improve eye health but dislike carrot by: Web Desk November 11, 2024 Carrots are often hailed as a superfood for eye…
Nov 8, 2024
FDA grants de novo authorization to photobiomodulation device for dry AMD
Key takeaways: The light delivery system maintained vision in a trial among patients with dry age-related macular degeneration. It is the first authorized treatment for vision loss related to dry…
Nov 7, 2024
Dropless cataract surgery: Shifting paradigm in postoperative care
Author(s): Monique M. Barbour, MD, Bria George, PharmD Key Takeaways Dropless cataract surgery eliminates postoperative eye drops, enhancing patient adherence and reducing complications like infection and inflammation. Intracameral drug delivery…
Nov 7, 2024
FDA clears investigational new drug application for wet AMD gene therapy
The FDA granted investigational drug clearance to HG202, a CRISPR/Cas13Y RNA-editing therapy for neovascular age-related macular degeneration, according to a press release from HuidaGene. According to the release, HG202 is the…
Nov 6, 2024
Intense pulsed light for treatment of dry eye disease
Author(s): David Hutton Joanne F. Shen, MD, director of the dry eye clinic at Mayo Clinic’s campus in Phoenix, Arizona, and a research team studied 35 patients treated with IPL/MGX.…
Nov 4, 2024
UV protection for the eyes: What patients need to know
October 29, 2024, By Cristina M. Schnider, OD, MSc, MBA, FAAO Many people know that invisible UV light can cause a sunburn and contribute to skin aging and skin cancer, but…
Oct 29, 2024
Daily consumption of pistachios boosts macular pigment optical density in healthy adults
October 28, 2024 Key takeaways: Eating 2 oz. of pistachios daily for 12 weeks significantly increased macular pigment optical density. Serum lutein concentration also improved in the group that consumed…
Oct 28, 2024
Genetic Links Explored: How inherited retinal dystrophies affect refractive errors in patients
Specific genes associated with inherited retinal dystrophies (IRDs) also influence refractive errors (RE), such as myopia and hyperopia, according to a study that found these genetic patterns vary widely, suggesting…
Oct 28, 2024
Alkeus Pharmaceuticals announces topline results from SAGA trial on GA treatment
October 25, 2024 ew study about Geographic Atrophy By Jordana Joy, Associate Editor The data showed a 15.3% reduction in the GA lesion growth rate versus placebo from 6 to 24…
Oct 23, 2024
#GIVING TUESDAY 2024
SAVE THE DATE: Tuesday December 3rd, 2024 #GivingTuesday—a movement to create a global day of giving Today. We need your help to help those Living with Macular Degeneration On Tuesday,…
Oct 22, 2024
Light therapy: Potential treatment for dry AMD
by: Lynda Charters Listen Key Takeaways Photobiomodulation may reduce visual loss and disease progression in dry AMD, offering a new treatment option for patients. The study showed significant visual acuity…
Oct 7, 2024
Metformin Shows Promise for Treating Macular Degeneration in Mice
A new study shows metformin may help prevent vision loss associated with age-related macular degeneration. News Published: October 7, 2024 Original story from the University of Chicago Age-related macular degeneration…
Sep 23, 2024
Alkeus Pharmaceuticals announces results from the SAGA study of oral gildeuretinol in patients with GA
September 19, 2024 By David Hutton Oral gildeuretinol demonstrated a clinically meaningful reduction in the geographic atrophy lesion growth rate at 24 months, supporting additional clinical development. SAGA topline data has…
Sep 19, 2024
Eye Drop Company in FDA’s Sights Once Again
The agency sounds alarm that products still may contain amniotic fluid by Kristina Fiore, Director of Enterprise & Investigative Reporting, MedPage Today September 17, 2024 The FDA has sent another letter — this…
Sep 16, 2024
These foods sabotage sleep
By Julia Ries | Fact-checked by Davi Sherman | Published September 13, 2024 Key Takeaways Certain foods like chocolate, greasy snacks, and spicy dishes can disrupt sleep due to their effects on digestion and caffeine content.…
Sep 12, 2024
The Changing Landscape of Nutrition in Medicine
A look at developments that have propelled us forward and those still to come for eye care. by: Julie Poteet, OD, MS, CNS, FOWNS At A Glance The increasing prevalence…
Sep 11, 2024
Up to 1 in 5 Dementia Cases May Be Attributable to Vision Impairment
Contrast sensitivity impairment showed the strongest relationship by Judy George, Deputy Managing Editor, MedPage TodaySeptember 5, 2024 Last Updated September 6, 2024 Key Takeaways Up to 19% of prevalent dementia cases may be…
Sep 9, 2024
AiViva Biopharma completes enrollment in Phase 1 clinical trial of AIV007 for AMD, DME
By David Hutton The Phase 1 trial is a multicenter, open-label, dose-escalation safety clinical trial, with 18 subjects, who each have received a single periocular injection of AIV007 AiViva Biopharma Inc…
Aug 21, 2024
AOA urges eye care provider consultation before use, purchase of MSM eye drops
August 20, 2024, By Jordana Joy, Associate Editor The alert follows a warning letter issued by the US FDA to a company that manufactures eye drops that claim to change eye…
Aug 15, 2024
Prevalence of AMD-related vision loss expected to increase as population ages
By Kate YoungFact checked by Heather Biele Key takeaways: Prevalence of AMD-related blindness decreased globally from 2000 to 2020. Older age is associated with greater prevalence of AMD-related vision loss.…